ADVERTISEMENT
News » Money
Nov 24, 4:48 PM EST

Denny's, Prosensa, Tesla and Lions Gate are big market movers

Business Video

Buy AP Photo Reprints
Interactives
Greece's Debt Threatens to Spread
State budget
gaps map
Auto industry problems trickle down, punish Tennessee county
Women give old Derby hats a makeover in tough economy
S.C. town deals with highest unemployment in South
How mortgages were bundled and sold as securities
Tracking the $700 billion financial bailout
Tracking the year's job losses
State-by-state foreclosures since 2007
Credit crisis explained
Presidents and their economic legacies
Lexicon of the financial crisis
Americans' addiction to debt
Interactive
Are Stocks Bouncing Back?

NEW YORK (AP) -- Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:

NYSE

Lions Gate Entertainment Corp., down 15 cents to $33.10

Despite its $123 million box office take, the studio's "Mockingjay, Part 1" fell short of previous installments in the "Hunger Games" film series.

United Technologies Corp., down $1.51 to $108.79

The defense conglomerate announced the abrupt retirement of CEO Louis Chenevert, and named Chief Financial Officer Greg Hayes to succeed him.

Exxon Mobil Corp., down $1.09 to $95.72

Analysts see crumbling crude prices if OPEC doesn't cut output when it meets this week and Raymond James downgraded the oil company's stock.

Trina Solar Ltd., down 57 cents to $10.36

The cancellation of a huge project in Inner Mongolia forced the solar company to cut its shipment forecast for the entire year.

Nasdaq

Tesla Motors Inc., up $3.94 to $246.72

CEO Elon Musk told Der Spiegel that the electric car maker is talking with BMW about a possible battery technology partnership.

Denny's Corp., up 70 cents to $9.59

Remodeled restaurants and improving trends in the family-dining sector bring an upgrade for the restaurateur from Janney Capital.

Prosensa Holding NV, up $7.16 to $18.60

BioMarin will pay $680 million in cash for the Dutch biotech company in a bid to strengthen its pipeline of genetic disorder drugs.

Five Prime Therapeutics Inc., up $4.95 to $20.70

The biotechnology company said that it will study a cancer drug regimen that combines one of its drugs with a therapy developed by Bristol-Myers Squibb.

© 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. Learn more about our Privacy Policy and Terms of Use.

 
ADVERTISEMENT